Antimicrobial Agents Practice Questions

Q: Quinolones are not effective in the treatment of which of the following?

Treponema. **Explanation:** The correct answer is **Treponema (Option B)**. **1. Why Treponema is the Correct Answer:** Quinolones (and Fluoroquinolones) act by inhibiting **DNA Gyrase** (Topoisomerase II) and **Topoisomerase IV**, enzymes essential for bacterial DNA replication. However, *Treponema pallidum* (the causative agent of Syphilis) is naturally resistant to fluoroquinolones. The primary treatment for Syphilis remains **Penicillin G**. Quinolones lack sufficient clinical efficacy against most spirochetes, making them ineffective for treating syphilis. **2. Why the other options are incorrect:** * **Mycobacteria (Option A):** Fluoroquinolones like Levofloxacin and Moxifloxacin are potent "second-line" anti-tubercular drugs. They are highly effective against *M. tuberculosis* and *M. leprae*. * **Haemophilus (Option C):** *Haemophilus influenzae* is highly sensitive to second and third-generation fluoroquinolones. They are frequently used to treat respiratory tract infections caused by this organism. * **Salmonella (Option D):** Fluoroquinolones (specifically Ciprofloxacin and Ceftriaxone) have traditionally been the drugs of choice for Enteric fever (Typhoid) caused by *Salmonella typhi*, though resistance is increasing (NALC - Nalidixic acid resistant strains). **Clinical Pearls for NEET-PG:** * **Respiratory Quinolones:** Levofloxacin, Moxifloxacin, and Gemifloxacin (enhanced activity against *S. pneumoniae*). * **Anti-pseudomonal Quinolones:** Ciprofloxacin and Pefloxacin. * **Mechanism of Resistance:** Most commonly due to mutations in the *gyrA* or *parC* genes or through Qnr proteins (plasmid-mediated). * **Key Side Effects:** Tendon rupture (Achilles tendon), QT prolongation, and contraindication in pregnancy/children due to cartilage toxicity.

Q: Adverse effects of isoniazid (INH) are all EXCEPT?

Hypothermia. **Explanation:** Isoniazid (INH) is a primary bactericidal drug used in the treatment of Tuberculosis. The correct answer is **Hypothermia**, as INH is actually associated with **drug-induced fever** (a hypersensitivity reaction), not a decrease in body temperature. **Analysis of Options:** * **Peripheral Neuritis (Option A):** This is the most common neurological side effect. INH interferes with pyridoxine (Vitamin B6) metabolism by inhibiting pyridoxine phosphokinase and increasing its renal excretion. This leads to a deficiency, resulting in paresthesia. It is prevented by co-administering **10–50 mg/day of Pyridoxine**. * **Hepatitis (Option B):** Hepatotoxicity is the most serious side effect of INH. It is caused by the metabolite **monoacetylhydrazine**. The risk increases with age, alcohol consumption, and in "fast acetylators" (though this is debated, fast acetylators produce the toxic metabolite more rapidly). * **Acne (Option D):** INH is a well-known cause of **drug-induced acneiform eruptions**. These typically appear as monomorphic pustules or papules on the trunk and arms, often lacking comedones. **High-Yield Clinical Pearls for NEET-PG:** 1. **Metabolism:** INH is metabolized via **Acetylation**. Genetic polymorphism (Slow vs. Fast acetylators) determines the half-life and toxicity profile. 2. **Sideroblastic Anemia:** INH can cause this due to interference with heme synthesis (which requires B6). 3. **Drug Interactions:** INH is a potent **Cytochrome P450 inhibitor**, increasing levels of phenytoin and carbamazepine. 4. **Systemic Lupus Erythematosus (SLE):** INH is a classic cause of **Drug-induced Lupus** (Anti-histone antibodies positive).

Q: A mother is breast-feeding her 2-month-old infant. Which one of the following drug situations involving the mother is unlikely to cause effects in the nursing infant?

Nystatin for a yeast infection. **Explanation:** The potential for a drug to affect a nursing infant depends on its ability to enter the maternal circulation and subsequently pass into breast milk [2]. **Why Nystatin is the correct answer:** Nystatin is a polyene antifungal that is **not absorbed** from the skin or gastrointestinal tract. When used topically (for cutaneous candidiasis) or orally (for oral thrush), its systemic absorption is negligible. Since the drug does not enter the mother’s bloodstream in significant quantities, it cannot be excreted into breast milk, making it safe for the nursing infant. **Why the other options are incorrect:** * **Ciprofloxacin:** Fluoroquinolones are excreted in breast milk. They carry a theoretical risk of causing arthropathy and cartilage damage in developing joints of the infant. * **Amphetamine:** These are small, lipophilic molecules that readily cross into breast milk. They can cause significant adverse effects in the infant, including irritability, poor sleeping patterns, and tachycardia. * **Triazolam:** As a benzodiazepine, it is lipid-soluble and passes into breast milk [2]. It can cause sedation, poor feeding [1], and potential respiratory depression in the neonate [3]. **NEET-PG High-Yield Pearls:** 1. **Drug Transfer Factors:** Drugs that are highly lipid-soluble, have low molecular weight, and low protein binding are more likely to cross into breast milk [2]. 2. **Safe Antibiotics:** Penicillins, Cephalosporins, and Erythromycin are generally considered safe during breastfeeding [1]. 3. **Absolute Contraindications:** Radioactive isotopes, Antineoplastic agents (Cyclophosphamide, Methotrexate), Lithium, Ergotamine, and recreational drugs are strictly contraindicated during lactation. 4. **Nystatin vs. Amphotericin B:** Both are polyenes, but Nystatin is too toxic for systemic use and is restricted to topical/local application.

Q: Trimethoprim acts by:

Inhibiting dihydrofolate reductase enzyme. ### Explanation **Correct Answer: B. Inhibiting dihydrofolate reductase enzyme** Trimethoprim is a synthetic antibiotic that interferes with bacterial folic acid synthesis. Bacteria cannot absorb preformed folic acid and must synthesize it de novo. Trimethoprim acts on the second step of this pathway by binding to and inhibiting the enzyme **dihydrofolate reductase (DHFR)**. This prevents the conversion of dihydrofolic acid to tetrahydrofolic acid (the active form), ultimately halting DNA synthesis and bacterial growth. **Analysis of Incorrect Options:** * **Option A & D:** These describe the mechanism of action for protein synthesis inhibitors. **Peptidyl transferase** is inhibited by **Chloramphenicol**, while binding to the **50S ribosomal subunit** is characteristic of Macrolides (e.g., Erythromycin), Clindamycin, and Linezolid. * **Option C:** **Dihydropteroate synthase** is the enzyme inhibited by **Sulfonamides**. Sulfonamides act on the first step of the folate pathway by competing with PABA (Para-aminobenzoic acid). **High-Yield Clinical Pearls for NEET-PG:** * **Cotrimoxazole:** This is a fixed-dose combination of **Sulfamethoxazole and Trimethoprim** in a **5:1 ratio**. This combination results in a **sequential blockade** of folate synthesis, making the effect bactericidal rather than bacteriostatic. * **Selectivity:** Trimethoprim has a much higher affinity (approx. 50,000 to 100,000 times) for bacterial DHFR than human DHFR, which accounts for its therapeutic safety. * **Pyrimethamine:** A related DHFR inhibitor used primarily for Malaria and Toxoplasmosis. * **Methotrexate:** A human DHFR inhibitor used as an anticancer and immunosuppressant drug. * **Side Effects:** Long-term use of Trimethoprim can lead to **megaloblastic anemia**, leukopenia, and granulocytopenia due to folate deficiency.

Q: DSM265 is having promising trials in the treatment of which disease?

Malaria. **DSM265** is a novel, long-acting antimalarial drug currently in clinical trials [1]. Its mechanism of action involves the potent and selective inhibition of **Plasmodium dihydroorotate dehydrogenase (DHODH)**. This enzyme is essential for the *de novo* synthesis of pyrimidines in the malaria parasite; since the parasite cannot salvage pre-formed pyrimidines, inhibiting DHODH effectively halts DNA and RNA synthesis, leading to parasite death.\n\n* **Why Malaria is Correct:** DSM265 is specifically designed to target both the liver stage (prophylaxis) and the blood stage (treatment) of *Plasmodium falciparum* and *Plasmodium vivax*. Its long half-life makes it a candidate for single-dose therapy, which would significantly improve compliance.\n* **Why other options are incorrect:**\n * **Tuberculosis:** Treatment focuses on inhibiting cell wall synthesis (Isoniazid, Ethambutol) or RNA polymerase (Rifampin). Novel TB drugs include Bedaquiline (ATP synthase inhibitor) and Delamanid.\n * **Leprosy:** Managed via MDT (Multi-Drug Therapy) involving Rifampicin, Dapsone, and Clofazimine.\n * **Trypanosoma:** Treated with drugs like Nifurtimox, Benznidazole (Chagas), or Suramin and Melarsoprol (Sleeping sickness).\n\n**High-Yield Clinical Pearls for NEET-PG:**\n* **Mechanism:** Selective inhibitor of **DHODH**.\n* **Target:** Effective against both *P. falciparum* and *P. vivax*.\n* **Advantage:** High metabolic stability allows for a **single-dose oral regimen**.\n* **Other New Antimalarials to watch:** **Tafenoquine** (8-aminoquinoline for radical cure of *P. vivax*) and **KAE609/Cipargamin** (inhibits PfATP4).

Q: What is the first-line drug for prophylaxis of pneumocystosis?

TMP-SMX. **Explanation:** **Pneumocystis jirovecii pneumonia (PCP)** is a significant opportunistic infection in immunocompromised patients, particularly those with HIV/AIDS (CD4 count <200 cells/mm³). **1. Why TMP-SMX is the Correct Answer:** **Trimethoprim-Sulfamethoxazole (TMP-SMX)**, also known as Co-trimoxazole, is the **first-line drug** for both the treatment and prophylaxis of pneumocystosis. It works by inhibiting sequential steps in the folic acid synthesis pathway of the fungus. It is preferred due to its high efficacy, low cost, and simultaneous protection against other pathogens like *Toxoplasma gondii* and certain bacterial respiratory infections. **2. Why Other Options are Incorrect:** * **B. Dapsone:** This is a **second-line** alternative for patients who are intolerant to TMP-SMX. It is less effective and requires screening for G6PD deficiency to avoid hemolytic anemia. * **C. Pyrimethamine:** While it also inhibits folic acid synthesis, it is primarily used in combination with Sulfadiazine for the treatment of **Toxoplasmosis**, not as a monotherapy or first-line agent for PCP. * **D. Atovaquone:** This is an alternative prophylactic agent used only when patients cannot tolerate both TMP-SMX and Dapsone. It is expensive and generally less effective than TMP-SMX. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis Indication:** Start in HIV patients when **CD4 count 35 mmHg) to prevent inflammation-induced respiratory failure. * **Alternative for severe cases:** IV Pentamidine (monitor for hypoglycemia and nephrotoxicity).

Q: What is the therapeutic advantage of penicillin V over penicillin G?

More reliable oral absorption. **Explanation:** The primary therapeutic advantage of **Penicillin V (Phenoxymethylpenicillin)** over **Penicillin G (Benzylpenicillin)** is its **acid stability**, which leads to more reliable oral absorption. 1. **Why Option A is correct:** Penicillin G is acid-labile and is rapidly destroyed by gastric acid, making its oral bioavailability poor and unpredictable (only about 1/3rd is absorbed). In contrast, Penicillin V is **acid-stable**, allowing it to pass through the stomach intact. This results in higher and more consistent plasma concentrations when administered orally. 2. **Why other options are incorrect:** * **Option B:** Neither Penicillin G nor V is resistant to penicillinase (beta-lactamase). Both are degraded by staphylococcal beta-lactamase. * **Option C:** Both drugs have a very short half-life (~30 minutes) and are rapidly excreted by the kidneys via active tubular secretion (80%) and glomerular filtration (20%). * **Option D:** Both drugs have a similar, narrow antibacterial spectrum, primarily targeting Gram-positive cocci (Streptococci) and some Gram-positive bacilli. **High-Yield NEET-PG Pearls:** * **Route of Choice:** Penicillin G is the drug of choice for **Syphilis** (administered parenterally). Penicillin V is used for minor infections like **Streptococcal pharyngitis** or tonsillitis. * **Probenecid Interaction:** Probenecid inhibits the renal tubular secretion of penicillins, thereby increasing their plasma concentration and prolonging their duration of action. * **Repository Forms:** Procaine and Benzathine Penicillin G are long-acting injectable forms designed to delay absorption, not to be confused with the oral stability of Penicillin V.

Q: What single-dose drug is used to treat gonorrhea in a 23-year-old pregnant female with severe amoxicillin sensitivity?

Ceftriaxone. **Explanation:** The treatment of choice for uncomplicated gonococcal infections is a single dose of **Ceftriaxone (Option A)**. According to current CDC and WHO guidelines, Ceftriaxone (500 mg IM) is the preferred agent due to its high efficacy and the rising resistance of *Neisseria gonorrhoeae* to other classes. **Why Ceftriaxone is correct despite "Amoxicillin Sensitivity":** In clinical practice, "severe amoxicillin sensitivity" often refers to a Type I IgE-mediated hypersensitivity (anaphylaxis). While there is a historical concern regarding cross-reactivity between penicillins and cephalosporins, the actual rate is **less than 1%** with third-generation cephalosporins like Ceftriaxone. In pregnancy, Ceftriaxone is considered safe (Category B) and remains the first-line recommendation. **Analysis of Incorrect Options:** * **Clindamycin (B):** This is a lincosamide used primarily for anaerobic infections and Gram-positive cocci; it has no clinical activity against *N. gonorrhoeae*. * **Ciprofloxacin (C):** Fluoroquinolones are no longer recommended for gonorrhea due to widespread resistance. Furthermore, they are generally avoided in pregnancy due to potential risks to fetal cartilage development. * **Spectinomycin (D):** While effective against gonorrhea and safe in pregnancy, it is an alternative agent used only when cephalosporins are contraindicated or unavailable. It is not the primary "drug of choice." **NEET-PG High-Yield Pearls:** * **Dual Therapy:** Historically, Ceftriaxone was paired with Azithromycin. Current guidelines now favor **Ceftriaxone monotherapy (500mg IM)** unless Chlamydia has not been excluded. * **Pregnancy Safety:** Ceftriaxone is the safest and most effective option for pregnant patients. * **Resistance:** Always remember that *N. gonorrhoeae* has developed high-level resistance to Penicillins, Tetracyclines, and Quinolones.

Question 1

Which of the following drugs is NOT used in the treatment of Taenia solium infection?

Accepted Answer

Niclosamide

Answer

Praziquantel

Answer

Albendazole

Answer

Flubendazole

Question 2

Which drug does not show an "after-treatment" reaction?

Accepted Answer

Isoniazid (INH)

Answer

Beta lactams

Answer

Ciprofloxacin

Answer

Gentamycin

Question 3

Quinolones are not effective in the treatment of which of the following?

Accepted Answer

Treponema

Answer

Mycobacteria

Answer

Haemophilus

Answer

Salmonella

Question 4

Adverse effects of isoniazid (INH) are all EXCEPT?

Accepted Answer

Hypothermia

Answer

Peripheral neuritis

Answer

Hepatitis

Answer

Acne

Question 5

A mother is breast-feeding her 2-month-old infant. Which one of the following drug situations involving the mother is unlikely to cause effects in the nursing infant?

Accepted Answer

Nystatin for a yeast infection

Answer

Ciprofloxacin for a urinary tract infection

Answer

Amphetamine for weight loss

Answer

Triazolam as a sleeping pill

Question 6

Trimethoprim acts by:

Accepted Answer

Inhibiting dihydrofolate reductase enzyme

Answer

Inhibiting peptidyl transferase enzyme

Answer

Inhibiting Dihydropteroate synthase enzyme

Answer

Binding to the 50s ribosomal unit and preventing protein synthesis

Question 7

DSM265 is having promising trials in the treatment of which disease?

Accepted Answer

Malaria

Answer

Tuberculosis

Answer

Leprosy

Answer

Trypanosoma

Question 8

What is the first-line drug for prophylaxis of pneumocystosis?

Accepted Answer

TMP-SMX

Answer

Dapsone

Answer

Pyrimethamine

Answer

Atovaquone

Question 9

What is the therapeutic advantage of penicillin V over penicillin G?

Accepted Answer

More reliable oral absorption

Answer

Greater resistance to penicillinase

Answer

Slower renal excretion

Answer

Broader antibacterial spectrum

Question 10

What single-dose drug is used to treat gonorrhea in a 23-year-old pregnant female with severe amoxicillin sensitivity?

Accepted Answer

Ceftriaxone

Answer

Clindamycin

Answer

Ciprofloxacin

Answer

Spectinomycin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?